Any 0 3 0 3 O
patient 4 11 4 11 O
with 12 16 12 16 O
a 17 18 17 18 O
hematological 19 32 19 32 B-chronic_disease
or 33 35 33 35 O
oncological 36 47 36 47 O
diagnosis 48 57 48 57 O
in 58 60 58 60 O
which 61 66 61 66 O
allogeneic 67 77 67 77 B-treatment
hematopoietic 78 91 78 91 I-treatment
stem 92 96 92 96 I-treatment
cell 97 101 97 101 I-treatment
transplantation 102 117 102 117 I-treatment
( 118 119 118 119 I-treatment
HSCT 119 123 119 123 I-treatment
) 123 124 123 124 I-treatment
is 125 127 125 127 O
thought 128 135 128 135 O
to 136 138 136 138 O
be 139 141 139 141 O
beneficial 142 152 142 152 O

For 0 3 153 156 O
patients 4 12 157 165 O
with 13 17 166 170 O
CMML 18 22 171 175 B-cancer
or 23 25 176 178 O
RAEB-2 26 32 179 185 B-chronic_disease
they 33 37 186 190 O
must 38 42 191 195 O
demonstrate 43 54 196 207 O
chemo 55 60 208 213 B-treatment
- 60 61 213 214 I-treatment
responsiveness 61 75 214 228 I-treatment

For 0 3 229 232 O
patients 4 12 233 241 O
with 13 17 242 246 O
RA 18 20 247 249 B-chronic_disease
or 21 23 250 252 O
RARS 24 28 253 257 B-clinical_variable
or 29 31 258 260 O
isolated 32 40 261 269 B-chronic_disease
5q- 41 44 270 273 I-chronic_disease
they 45 49 274 278 O
can 50 53 279 282 O
proceed 54 61 283 290 O
to 62 64 291 293 O
transplant 65 75 294 304 B-treatment
without 76 83 305 312 O
any 84 87 313 316 O
treatment 88 97 317 326 B-treatment

For 0 3 327 330 O
patients 4 12 331 339 O
with 13 17 340 344 O
RAEB-1 18 24 345 351 B-cancer
, 24 25 351 352 O
RCMD+/-RS 26 35 353 362 B-cancer
, 35 36 362 363 O
or 37 39 364 366 O
MDS 40 43 367 370 B-cancer
NOS 44 47 371 374 I-cancer
must 48 52 375 379 O
have 53 57 380 384 O
stable 58 64 385 391 O
disease 65 72 392 399 O
for 73 76 400 403 O
6 77 78 404 405 B-upper_bound
months 79 85 406 412 I-upper_bound
( 86 87 413 414 O
as 87 89 414 416 O
documented 90 100 417 427 O
by 101 103 428 430 O
serial 104 110 431 437 O
bone 111 115 438 442 O
marrow 116 122 443 449 O
examinations 123 135 450 462 O
) 135 136 462 463 O
in 137 139 464 466 O
the 140 143 467 470 O
absence 144 151 471 478 O
of 152 154 479 481 O
any 155 158 482 485 O
therapy 159 166 486 493 B-treatment
but 167 170 494 497 O
growth 171 177 498 504 O
factors 178 185 505 512 O
or 186 188 513 515 O
transfusion 189 200 516 527 O
support 201 208 528 535 O
. 208 209 535 536 O
Patients 210 218 537 545 O
who 219 222 546 549 O
require 223 230 550 557 O
treatment 231 240 558 567 B-treatment
to 241 243 568 570 O
control 244 251 571 578 O
their 252 257 579 584 O
disease 258 265 585 592 O
must 266 270 593 597 O
show 271 275 598 602 O
chemo 276 281 603 608 O
- 281 282 608 609 O
responsiveness 282 296 609 623 O

Patients 0 8 624 632 O
must 9 13 633 637 O
be 14 16 638 640 O
willing 17 24 641 648 B-contraception_consent
to 25 27 649 651 I-contraception_consent
use 28 31 652 655 I-contraception_consent
contraception 32 45 656 669 I-contraception_consent
if 46 48 670 672 O
they 49 53 673 677 O
are 54 57 678 681 O
of 58 60 682 684 O
childbearing 61 73 685 697 O
potential 74 83 698 707 O

Patients 0 8 708 716 O
who 9 12 717 720 O
can 13 16 721 724 O
not 16 19 724 727 O
receive 20 27 728 735 O
cyclophosphamide 28 44 736 752 B-treatment

Patients 0 8 753 761 O
who 9 12 762 765 O
have 13 17 766 770 O
received 18 26 771 779 O
alemtuzumab 27 38 780 791 B-treatment
within 39 45 792 798 O
8 46 47 799 800 B-upper_bound
weeks 48 53 801 806 I-upper_bound
of 54 56 807 809 O
the 57 60 810 813 O
transplant 61 71 814 824 B-treatment
admission 72 81 825 834 O
, 81 82 834 835 O
or 83 85 836 838 O
who 86 89 839 842 O
have 90 94 843 847 O
recently 95 103 848 856 O
received 104 112 857 865 O
horse 113 118 866 871 B-treatment
or 119 121 872 874 I-treatment
rabbit 122 128 875 881 I-treatment
ant 129 132 882 885 I-treatment
- 132 133 885 886 I-treatment
thymocyte 133 142 886 895 I-treatment
globulin 143 151 896 904 I-treatment
and 152 155 905 908 O
have 156 160 909 913 O
an 161 163 914 916 O
ATG 164 167 917 920 B-clinical_variable
level 168 173 921 926 I-clinical_variable
of 174 176 927 929 O
> 177 178 930 931 O
2 179 180 932 933 B-lower_bound
Î¼g 181 183 934 936 I-lower_bound
/ 183 184 936 937 I-lower_bound
ml 184 186 937 939 I-lower_bound
. 186 187 939 940 O
Patients 188 196 941 949 O
on 197 199 950 952 O
systemic 200 208 953 961 B-treatment
corticosteroids 209 224 962 977 I-treatment
at 225 227 978 980 O
a 228 229 981 982 O
dose 230 234 983 987 O
equivalent 235 245 988 998 O
of 246 248 999 1001 O
prednisone 249 259 1002 1012 B-treatment
7.5mg 260 265 1013 1018 B-lower_bound
/ 265 266 1018 1019 I-lower_bound
day 266 269 1019 1022 I-lower_bound
or 270 272 1023 1025 O
higher 273 279 1026 1032 O

Patients 0 8 1033 1041 O
who 9 12 1042 1045 O
require 13 20 1046 1053 O
supplemental 21 33 1054 1066 O
oxygen 34 40 1067 1073 O
other 41 46 1074 1079 O
than 47 51 1080 1084 O
for 52 55 1085 1088 O
sleep 56 61 1089 1094 B-chronic_disease
apnea 62 67 1095 1100 I-chronic_disease

Patients 0 8 1101 1109 O
with 9 13 1110 1114 O
a 14 15 1115 1116 O
psychiatric 16 27 1117 1128 B-chronic_disease
disorder 28 36 1129 1137 I-chronic_disease
that 37 41 1138 1142 O
would 42 47 1143 1148 O
preclude 48 56 1149 1157 O
patients 57 65 1158 1166 O
from 66 70 1167 1171 O
complying 71 80 1172 1181 O
with 81 85 1182 1186 O
the 86 89 1187 1190 O
protocol 90 98 1191 1199 O
even 99 103 1200 1204 O
with 104 108 1205 1209 O
a 109 110 1210 1211 O
caregiver 111 120 1212 1221 O
. 120 121 1221 1222 O
Patients 122 130 1223 1231 O
with 131 135 1232 1236 O
a 136 137 1237 1238 O
lack 138 142 1239 1243 O
of 143 145 1244 1246 O
social 146 152 1247 1253 O
support 153 160 1254 1261 O
that 161 165 1262 1266 O
would 166 171 1267 1272 O
interfere 172 181 1273 1282 O
with 182 186 1283 1287 O
the 187 190 1288 1291 O
ability 191 198 1292 1299 O
to 199 201 1300 1302 O
receive 202 209 1303 1310 O
appropriate 210 221 1311 1322 O
medical 222 229 1323 1330 O
care 230 234 1331 1335 O

Patients 0 8 1336 1344 O
with 9 13 1345 1349 O
active 14 20 1350 1356 O
involvement 21 32 1357 1368 O
of 33 35 1369 1371 O
the 36 39 1372 1375 O
central 40 47 1376 1383 B-cancer
nervous 48 55 1384 1391 I-cancer
system 56 62 1392 1398 I-cancer
with 63 67 1399 1403 I-cancer
malignancy 68 78 1404 1414 I-cancer
. 78 79 1414 1415 O
Patients 80 88 1416 1424 O
with 89 93 1425 1429 O
a 94 95 1430 1431 O
disease 96 103 1432 1439 O
with 104 108 1440 1444 O
potential 109 118 1445 1454 O
for 119 122 1455 1458 O
CNS 123 126 1459 1462 O
involvement 127 138 1463 1474 O
should 139 145 1475 1481 O
have 146 150 1482 1486 O
documentation 151 164 1487 1500 O
of 165 167 1501 1503 O
the 168 171 1504 1507 O
lack 172 176 1508 1512 O
of 177 179 1513 1515 O
CNS 180 183 1516 1519 O
involvement 184 195 1520 1531 O
via 196 199 1532 1535 O
lumbar 200 206 1536 1542 B-treatment
puncture 207 215 1543 1551 I-treatment
or 216 218 1552 1554 O
similar 219 226 1555 1562 O
procedure 227 236 1563 1572 O
performed 237 246 1573 1582 O
within 247 253 1583 1589 O
two 254 257 1590 1593 B-upper_bound
months 258 264 1594 1600 I-upper_bound
of 265 267 1601 1603 O
admission 268 277 1604 1613 O
or 278 280 1614 1616 O
as 281 283 1617 1619 O
per 284 287 1620 1623 O
TJU 288 291 1624 1627 O
standard 292 300 1628 1636 O
practice 301 309 1637 1645 O
guidelines 310 320 1646 1656 O

Patients 0 8 1657 1665 O
with 9 13 1666 1670 O
evidence 14 22 1671 1679 O
of 23 25 1680 1682 O
another 26 33 1683 1690 O
malignancy 34 44 1691 1701 B-cancer
, 44 45 1701 1702 O
exclusive 46 55 1703 1712 O
of 56 58 1713 1715 O
a 59 60 1716 1717 O
skin 61 65 1718 1722 B-cancer
cancer 66 72 1723 1729 I-cancer
that 73 77 1730 1734 O
requires 78 86 1735 1743 O
only 87 91 1744 1748 O
local 92 97 1749 1754 O
treatment 98 107 1755 1764 B-treatment
, 107 108 1764 1765 O
should 109 115 1766 1772 O
not 116 119 1773 1776 O
be 120 122 1777 1779 O
enrolled 123 131 1780 1788 O
on 132 134 1789 1791 O
this 135 139 1792 1796 O
protocol 140 148 1797 1805 O

Patients 0 8 1806 1814 O
with 9 13 1815 1819 O
life 14 18 1820 1824 B-clinical_variable
expectancy 19 29 1825 1835 I-clinical_variable
of 30 32 1836 1838 O
< 33 34 1839 1840 O
6 35 36 1841 1842 B-upper_bound
months 37 43 1843 1849 I-upper_bound
for 44 47 1850 1853 O
reasons 48 55 1854 1861 O
other 56 61 1862 1867 O
than 62 66 1868 1872 O
their 67 72 1873 1878 O
underlying 73 83 1879 1889 O
hematological 84 97 1890 1903 B-chronic_disease
/ 97 98 1903 1904 O
oncological 98 109 1904 1915 B-chronic_disease
disorder 110 118 1916 1924 I-chronic_disease

Patients 0 8 1925 1933 O
with 9 13 1934 1938 O
refractory 14 24 1939 1949 B-chronic_disease
disease 25 32 1950 1957 I-chronic_disease

Patients 0 8 1958 1966 O
with 9 13 1967 1971 O
related 14 21 1972 1979 O
donors 22 28 1980 1986 O
must 29 33 1987 1991 O
have 34 38 1992 1996 O
a 39 40 1997 1998 O
DLCO 41 45 1999 2003 B-clinical_variable
> 46 47 2004 2005 O
35 47 49 2005 2007 B-lower_bound
% 49 50 2007 2008 I-lower_bound
of 51 53 2009 2011 O
predicted 54 63 2012 2021 O
corrected 64 73 2022 2031 O
for 74 77 2032 2035 O
hemoglobin 78 88 2036 2046 B-clinical_variable
. 88 89 2046 2047 O
Patients 90 98 2048 2056 O
with 99 103 2057 2061 O
unrelated 104 113 2062 2071 O
donors 114 120 2072 2078 O
must 121 125 2079 2083 O
have 126 130 2084 2088 O
a 131 132 2089 2090 O
DLCO 133 137 2091 2095 O
> 138 139 2096 2097 O
45 139 141 2097 2099 O
% 141 142 2099 2100 O
of 143 145 2101 2103 O
predicted 146 155 2104 2113 O
corrected 156 165 2114 2123 O
for 166 169 2124 2127 O
hemoglobin 170 180 2128 2138 O
. 180 181 2138 2139 O
For 182 185 2140 2143 O
related 186 193 2144 2151 O
donors 194 200 2152 2158 O
if 201 203 2159 2161 O
the 204 207 2162 2165 O
DLCO 208 212 2166 2170 O
is 213 215 2171 2173 O
less 216 220 2174 2178 O
than 221 225 2179 2183 O
45 226 228 2184 2186 O
% 228 229 2186 2187 O
the 230 233 2188 2191 O
EF 234 236 2192 2194 B-clinical_variable
must 237 241 2195 2199 O
be 242 244 2200 2202 O
greater 245 252 2203 2210 O
than 253 257 2211 2215 O
45 258 260 2216 2218 O
% 260 261 2218 2219 O
and 262 265 2220 2223 O
vice 266 270 2224 2228 O
versa 271 276 2229 2234 O

Patients 0 8 2235 2243 O
with 9 13 2244 2248 O
related 14 21 2249 2256 O
donors 22 28 2257 2263 O
must 29 33 2264 2268 O
have 34 38 2269 2273 O
a 39 40 2274 2275 O
HCT 41 44 2276 2279 B-clinical_variable
- 44 45 2279 2280 I-clinical_variable
CI 45 47 2280 2282 I-clinical_variable
Score 48 53 2283 2288 I-clinical_variable
< 54 55 2289 2290 O
6 56 57 2291 2292 B-upper_bound
Points 58 64 2293 2299 I-upper_bound
( 65 66 2300 2301 O
Appendix 66 74 2301 2309 O
B 75 76 2310 2311 O
) 76 77 2311 2312 O
. 77 78 2312 2313 O
Patients 79 87 2314 2322 O
with 88 92 2323 2327 O
unrelated 93 102 2328 2337 O
donors 103 109 2338 2344 O
must 110 114 2345 2349 O
have 115 119 2350 2354 O
a 120 121 2355 2356 O
HCT 122 125 2357 2360 O
- 125 126 2360 2361 O
CI 126 128 2361 2363 O
Score 129 134 2364 2369 O
< 135 136 2370 2371 O
5 137 138 2372 2373 B-upper_bound
Points 139 145 2374 2380 I-upper_bound

Patients 0 8 2381 2389 O
with 9 13 2390 2394 O
related 14 21 2395 2402 O
donors 22 28 2403 2409 O
must 29 33 2410 2414 O
have 34 38 2415 2419 O
a 39 40 2420 2421 O
performance 41 52 2422 2433 B-clinical_variable
status 53 59 2434 2440 I-clinical_variable
> 60 61 2441 2442 O
60 62 64 2443 2445 B-lower_bound
% 64 65 2445 2446 I-lower_bound
( 66 67 2447 2448 O
TJU 67 70 2448 2451 B-clinical_variable
Karnofsky14 71 82 2452 2463 I-clinical_variable
) 82 83 2463 2464 O
( 84 85 2465 2466 O
Appendix 85 93 2466 2474 O
A 94 95 2475 2476 O
) 95 96 2476 2477 O
. 96 97 2477 2478 O
Patients 98 106 2479 2487 O
with 107 111 2488 2492 O
unrelated 112 121 2493 2502 O
donors 122 128 2503 2509 O
must 129 133 2510 2514 O
have 134 138 2515 2519 O
a 139 140 2520 2521 O
Performance 141 152 2522 2533 B-clinical_variable
status 153 159 2534 2540 I-clinical_variable
> 160 161 2541 2542 O
70 162 164 2543 2545 B-lower_bound
% 164 165 2545 2546 I-lower_bound
( 166 167 2547 2548 O
TJU 167 170 2548 2551 O
Karnofsky 171 180 2552 2561 O
) 180 181 2561 2562 O

Patients 0 8 2563 2571 O
with 9 13 2572 2576 O
related 14 21 2577 2584 O
donors 22 28 2585 2591 O
must 29 33 2592 2596 O
have 34 38 2597 2601 O
an 39 41 2602 2604 O
LVEF 42 46 2605 2609 B-clinical_variable
of 47 49 2610 2612 O
> 50 51 2613 2614 O
35 51 53 2614 2616 B-lower_bound
% 53 54 2616 2617 I-lower_bound
. 54 55 2617 2618 O
Patients 56 64 2619 2627 O
with 65 69 2628 2632 O
unrelated 70 79 2633 2642 O
donors 80 86 2643 2649 O
must 87 91 2650 2654 O
have 92 96 2655 2659 O
an 97 99 2660 2662 O
LVEF 100 104 2663 2667 O
> 105 106 2668 2669 O
45 106 108 2669 2671 B-lower_bound
% 108 109 2671 2672 I-lower_bound
. 109 110 2672 2673 O
Patients 111 119 2674 2682 O
with 120 124 2683 2687 O
LVEF 125 129 2688 2692 O
â¤50 130 133 2693 2696 O
% 133 134 2696 2697 I-upper_bound
and 135 138 2698 2701 O
all 139 142 2702 2705 O
patients 143 151 2706 2714 O
with 152 156 2715 2719 O
symptoms 157 165 2720 2728 O
or 166 168 2729 2731 O
history 169 176 2732 2739 O
of 177 179 2740 2742 O
heart 180 185 2743 2748 B-chronic_disease
failure 186 193 2749 2756 I-chronic_disease
or 194 196 2757 2759 O
coronary 197 205 2760 2768 B-chronic_disease
artery 206 212 2769 2775 I-chronic_disease
disease 213 220 2776 2783 I-chronic_disease
must 221 225 2784 2788 O
have 226 230 2789 2793 O
a 231 232 2794 2795 O
stress 233 239 2796 2802 O
echo 240 244 2803 2807 O
or 245 247 2808 2810 O
equivalent 248 258 2811 2821 O
test 259 263 2822 2826 O
and 264 267 2827 2830 O
a 268 269 2831 2832 O
cardiological 270 283 2833 2846 O
evaluation 284 294 2847 2857 O

Patients 0 8 2858 2866 O
with 9 13 2867 2871 O
related 14 21 2872 2879 O
donors 22 28 2880 2886 O
must 29 33 2887 2891 O
have 34 38 2892 2896 O
an 39 41 2897 2899 O
adequate 42 50 2900 2908 O
liver 51 56 2909 2914 O
function 57 65 2915 2923 O
as 66 68 2924 2926 O
defined 69 76 2927 2934 O
by 77 79 2935 2937 O
a 80 81 2938 2939 O
serum 82 87 2940 2945 B-clinical_variable
bilirubin 88 97 2946 2955 I-clinical_variable
< 98 99 2956 2957 O
3.0 99 102 2957 2960 B-upper_bound
, 102 103 2960 2961 O
AST 104 107 2962 2965 B-clinical_variable
and 108 111 2966 2969 O
ALT 112 115 2970 2973 B-clinical_variable
< 116 117 2974 2975 O
3.0X 117 121 2975 2979 B-upper_bound
upper 122 127 2980 2985 I-upper_bound
limit 128 133 2986 2991 I-upper_bound
of 134 136 2992 2994 I-upper_bound
normal 137 143 2995 3001 I-upper_bound
. 143 144 3001 3002 O
Patients 145 153 3003 3011 O
with 154 158 3012 3016 O
unrelated 159 168 3017 3026 O
donors 169 175 3027 3033 O
must 176 180 3034 3038 O
have 181 185 3039 3043 O
an 186 188 3044 3046 O
adequate 189 197 3047 3055 O
liver 198 203 3056 3061 O
function 204 212 3062 3070 O
as 213 215 3071 3073 O
defined 216 223 3074 3081 O
by 224 226 3082 3084 O
a 227 228 3085 3086 O
serum 229 234 3087 3092 O
bilirubin 235 244 3093 3102 O
< 245 246 3103 3104 O
1.8 246 249 3104 3107 B-upper_bound
, 249 250 3107 3108 O
AST 251 254 3109 3112 O
and 255 258 3113 3116 O
ALT 259 262 3117 3120 O
< 263 264 3121 3122 O
2.5X 265 269 3123 3127 B-upper_bound
upper 270 275 3128 3133 I-upper_bound
limit 276 281 3134 3139 I-upper_bound
of 282 284 3140 3142 I-upper_bound
normal 285 291 3143 3149 I-upper_bound
. 291 292 3149 3150 O
Exceptions 293 303 3151 3161 O
may 304 307 3162 3165 O
be 308 310 3166 3168 O
granted 311 318 3169 3176 O
for 319 322 3177 3180 O
patients 323 331 3181 3189 O
with 332 336 3190 3194 O
benign 337 343 3195 3201 O
liver 344 349 3202 3207 B-chronic_disease
disorders 350 359 3208 3217 I-chronic_disease
such 360 364 3218 3222 O
as 365 367 3223 3225 O
Gilbert 368 375 3226 3233 B-chronic_disease
's 375 377 3233 3235 I-chronic_disease
disease 378 385 3236 3243 I-chronic_disease

Patients 0 8 3244 3252 O
with 9 13 3253 3257 O
related 14 21 3258 3265 O
donors 22 28 3266 3272 O
or 29 31 3273 3275 O
with 32 36 3276 3280 O
unrelated 37 46 3281 3290 O
donors 47 53 3291 3297 O
must 54 58 3298 3302 O
have 59 63 3303 3307 O
a 64 65 3308 3309 O
creatinine 66 76 3310 3320 B-clinical_variable
clearance 77 86 3321 3330 I-clinical_variable
of 87 89 3331 3333 O
> 90 91 3334 3335 O
60 92 94 3336 3338 B-lower_bound
ml 95 97 3339 3341 I-lower_bound
/ 97 98 3341 3342 I-lower_bound
min/1.73 98 106 3342 3350 I-lower_bound
m^2 107 110 3351 3354 I-lower_bound

Patients 0 8 3355 3363 O
with 9 13 3364 3368 O
related 14 21 3369 3376 O
donors 22 28 3377 3383 O
who 29 32 3384 3387 O
have 33 37 3388 3392 O
a 38 39 3393 3394 O
combination 40 51 3395 3406 O
of 52 54 3407 3409 O
Performance 55 66 3410 3421 B-clinical_variable
status 67 73 3422 3428 I-clinical_variable
of 74 76 3429 3431 O
< 77 78 3432 3433 O
70 79 81 3434 3436 B-upper_bound
% 81 82 3436 3437 I-upper_bound
( 83 84 3438 3439 O
TJU 84 87 3439 3442 B-clinical_variable
Karnofsky 88 97 3443 3452 I-clinical_variable
) 97 98 3452 3453 O
and 99 102 3454 3457 O
an 103 105 3458 3460 O
HCT 106 109 3461 3464 B-clinical_variable
- 109 110 3464 3465 I-clinical_variable
CI 110 112 3465 3467 I-clinical_variable
of 113 115 3468 3470 O
4 116 117 3471 3472 B-lower_bound
points 118 124 3473 3479 I-lower_bound
or 125 127 3480 3482 O
more 128 132 3483 3487 O
. 132 133 3487 3488 O
Patients 134 142 3489 3497 O
with 143 147 3498 3502 O
unrelated 148 157 3503 3512 O
donors 158 164 3513 3519 O
with 165 169 3520 3524 O
a 170 171 3525 3526 O
combination 172 183 3527 3538 O
of 184 186 3539 3541 O
Performance 187 198 3542 3553 O
status 199 205 3554 3560 O
of 206 208 3561 3563 O
< 209 210 3564 3565 O
80 211 213 3566 3568 B-upper_bound
% 213 214 3568 3569 I-upper_bound
( 215 216 3570 3571 O
TJU 216 219 3571 3574 O
Karnofsky 220 229 3575 3584 O
) 229 230 3584 3585 O
and 231 234 3586 3589 O
an 235 237 3590 3592 O
HCT 238 241 3593 3596 O
- 241 242 3596 3597 O
CI 242 244 3597 3599 O
of 245 247 3600 3602 O
4 248 249 3603 3604 O
points 250 256 3605 3611 O
or 257 259 3612 3614 O
more 260 264 3615 3619 O

Pregnancy 0 9 3620 3629 B-pregnancy

patients 0 8 3630 3638 O
with 9 13 3639 3643 O
MDS 14 17 3644 3647 B-cancer

